DrugPatentWatch Database Preview
Drugs in Development Information for RRx-001
Development status for investigational drug RRx-001: Sponsors, patents, clinical trial progress
RRx-001 is an investigational drug.
There have been 11 clinical trials for RRx-001.
The most recent clinical trial was a Phase 1 trial, which was initiated on November 1st 2018.
The most common disease conditions in clinical trials are Lymphoma, Carcinoma, and Small Cell Lung Carcinoma. The leading clinical trial sponsors are EpicentRx, Inc., Drais Pharmaceuticals, Inc., and [disabled in preview].
There are seven US patents protecting this investigational drug and thirty-eight international patents.
Summary for RRx-001
| US Patents | 7 |
| International Patents | 38 |
| US Patent Applications | 10 |
| WIPO Patent Applications | 3 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 1 (2018-11-01) |
| Vendors | 28 |
Recent Clinical Trials for RRx-001
| Title | Sponsor | Phase |
|---|---|---|
| RRx-001 Prior to a Platinum Doublet or a Platinum Doublet Alone in Patients With Small Cell Carcinoma | EpicentRx, Inc. | Phase 3 |
| Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers | Drais Pharmaceuticals, Inc. | Phase 2 |
| Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Chemoradiation for the Treatment of Oral Cancers | EpicentRx, Inc. | Phase 2 |
Clinical Trial Summary for RRx-001
Top disease conditions for RRx-001
Top clinical trial sponsors for RRx-001
US Patents for RRx-001
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| RRx-001 | See Pricing | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | RadioRx, Inc. (Menlo Park, CA) Alliant Techsystems Inc. (Edina, MN) | See Pricing |
| RRx-001 | See Pricing | Methods of synthesizing cyclic nitro compounds | Alliant Techsystems Inc. (Minneapolis, MN) | See Pricing |
| RRx-001 | See Pricing | Methods of synthesizing cyclic nitro compounds | Alliant Techsystems Inc. (Arlington, VA) | See Pricing |
| RRx-001 | See Pricing | Cyclic nitro compounds, pharmaceutical compositions thereof and uses thereof | RadioRx, Inc. (Menlo Park, CA) Alliant Techsystems Inc. (Minneapolis, MN) | See Pricing |
| RRx-001 | See Pricing | Methods of synthesizing and isolating N-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | Alliant Techsystems Inc. (Arlington, VA) | See Pricing |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for RRx-001
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| RRx-001 | Australia | 2006279589 | 2025-08-12 | See Pricing |
| RRx-001 | Canada | 2620612 | 2025-08-12 | See Pricing |
| RRx-001 | China | 101370492 | 2025-08-12 | See Pricing |
| RRx-001 | Cyprus | 1116094 | 2025-08-12 | See Pricing |
| RRx-001 | Denmark | 1924253 | 2025-08-12 | See Pricing |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
